New Treatments
Researching Faster Cures
TB Alliance is not just developing new drugs, but changing the way TB drugs are developed.
Learn MoreMore news:
- TB Alliance Welcomes New Data on BPaL-Based Regimens Presented at the 2021 Union Conference
- WHO Global Tuberculosis Report—New Drugs and Regimens Need to be Combined with Equitable and Universal Access
- New Trial Results Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB Can Be Maintained with Reduced Dosing of Linezolid
The Latest From TB Alliance
TB by the Numbers
1.4 Million
Tuberculosis (TB) is a global pandemic, killing someone approximately every 22 seconds — about 1.4 million in 2019 alone.
Get the facts6-30 Months
Today's TB drug regimen takes too long to cure, is too complicated to administer, and can be toxic.
Learn More30+ Projects
Promise in the pipeline means new hope in stopping TB.
Reaching Those In Need
Delivering Treatments
TB Alliance's mission is not complete until new drugs are in the hands of those who need them.
Learn More
